Literature DB >> 11024109

Human T-lymphotropic virus type 1 open reading frame I p12(I) is required for efficient viral infectivity in primary lymphocytes.

B Albrecht1, N D Collins, M T Burniston, J W Nisbet, L Ratner, P L Green, M D Lairmore.   

Abstract

Human T-lymphotropic virus type 1 (HTLV-1) is a complex retrovirus encoding regulatory and accessory genes in four open reading frames (ORF I to IV) of the pX region. Emerging evidence indicates an important role for the pX ORF I-encoded accessory protein p12(I) in viral replication, but its contribution to viral pathogenesis remains to be defined. p12(I) is a conserved, membrane-associated protein containing four SH3-binding motifs (PXXP). Its interaction with the interleukin-2 (IL-2) receptor beta- and gamma-chains implies an involvement of p12(I) in intracellular signaling pathways. In addition, we have demonstrated that expression of pX ORF I p12(I) is essential for persistent infection in rabbits. In contrast, standard in vitro systems have thus far failed to demonstrate a contribution of p12(I) to viral infectivity and ultimately cellular transformation. In this study we developed multiple in vitro coculture assays to evaluate the role of p12(I) in viral infectivity in quiescent peripheral blood mononuclear cells to more accurately reflect the virus-cell interactions as they occur in vivo. Using these assays, we demonstrate a dramatic reduction in viral infectivity in quiescent T lymphocytes for a p12 mutant viral clone (ACH.p12) in comparison to the wild-type clone ACH. Moreover, addition of IL-2 and phytohemagglutinin during the infection completely rescued the ability of ACH.p12 to infect primary lymphocytes. When newly infected primary lymphocytes are used to passage virus, ACH.p12 also exhibited a reduced ability to productively infect activated lymphocytes. Our data are the first to demonstrate a functional role for pX ORF I in the infection of primary lymphocytes and suggest a role for p12(I) in activation of host cells during early stages of infection.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11024109      PMCID: PMC102019          DOI: 10.1128/jvi.74.21.9828-9835.2000

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  41 in total

Review 1.  Interactions of HIV-1 NEF with cellular signal transducing proteins.

Authors:  G H Renkema; K Saksela
Journal:  Front Biosci       Date:  2000-02-01

2.  Induction of AIDS in rhesus monkeys by molecularly cloned simian immunodeficiency virus.

Authors:  H Kestler; T Kodama; D Ringler; M Marthas; N Pedersen; A Lackner; D Regier; P Sehgal; M Daniel; N King
Journal:  Science       Date:  1990-06-01       Impact factor: 47.728

3.  X-I and X-II open reading frames of HTLV-I are not required for virus replication or for immortalization of primary T-cells in vitro.

Authors:  D Derse; J Mikovits; F Ruscetti
Journal:  Virology       Date:  1997-10-13       Impact factor: 3.616

4.  The conserved core of human immunodeficiency virus type 1 Nef is essential for association with Lck and for enhanced viral replication in T-lymphocytes.

Authors:  H Cheng; J P Hoxie; W P Parks
Journal:  Virology       Date:  1999-11-10       Impact factor: 3.616

5.  Type C virus particles in a cord T-cell line derived by co-cultivating normal human cord leukocytes and human leukaemic T cells.

Authors:  I Miyoshi; I Kubonishi; S Yoshimoto; T Akagi; Y Ohtsuki; Y Shiraishi; K Nagata; Y Hinuma
Journal:  Nature       Date:  1981-12-24       Impact factor: 49.962

6.  Mitogen requirements for the in vitro propagation of cutaneous T-cell lymphomas.

Authors:  A F Gazdar; D N Carney; P A Bunn; E K Russell; E S Jaffe; G P Schechter; J G Guccion
Journal:  Blood       Date:  1980-03       Impact factor: 22.113

7.  The decreased replicative capacity of simian immunodeficiency virus SIVmac239Delta(nef) is manifest in cultures of immature dendritic cellsand T cells.

Authors:  D Messmer; R Ignatius; C Santisteban; R M Steinman; M Pope
Journal:  J Virol       Date:  2000-03       Impact factor: 5.103

8.  Mapping of immunogenic regions of human T cell leukemia virus type I (HTLV-I) gp46 and gp21 envelope glycoproteins with env-encoded synthetic peptides and a monoclonal antibody to gp46.

Authors:  T J Palker; M E Tanner; R M Scearce; R D Streilein; M E Clark; B F Haynes
Journal:  J Immunol       Date:  1989-02-01       Impact factor: 5.422

9.  Persistent infection of rabbits with HTLV-I: patterns of anti-viral antibody reactivity and detection of virus by gene amplification.

Authors:  G L Cockerell; M Lairmore; B De; J Rovnak; T M Hartley; I Miyoshi
Journal:  Int J Cancer       Date:  1990-01-15       Impact factor: 7.396

10.  Evidence for the chronic in vivo production of human T cell leukemia virus type I Rof and Tof proteins from cytotoxic T lymphocytes directed against viral peptides.

Authors:  C Pique; A Ureta-Vidal; A Gessain; B Chancerel; O Gout; R Tamouza; F Agis; M C Dokhélar
Journal:  J Exp Med       Date:  2000-02-07       Impact factor: 14.307

View more
  53 in total

Review 1.  Animal models for human T-lymphotropic virus type 1 (HTLV-1) infection and transformation.

Authors:  Michael D Lairmore; Lee Silverman; Lee Ratner
Journal:  Oncogene       Date:  2005-09-05       Impact factor: 9.867

2.  Detection and quantitation of HTLV-1 and HTLV-2 mRNA species by real-time RT-PCR.

Authors:  Min Li; Patrick L Green
Journal:  J Virol Methods       Date:  2007-03-06       Impact factor: 2.014

3.  Enhancement of LFA-1-mediated T cell adhesion by human T lymphotropic virus type 1 p12I1.

Authors:  Seung-Jae Kim; Amrithraj M Nair; Soledad Fernandez; Lawrence Mathes; Michael D Lairmore
Journal:  J Immunol       Date:  2006-05-01       Impact factor: 5.422

4.  The SCHOOL of nature: III. From mechanistic understanding to novel therapies.

Authors:  Alexander B Sigalov
Journal:  Self Nonself       Date:  2010-06-11

5.  Human T-cell lymphotropic virus type 1 p12(I) expression increases cytoplasmic calcium to enhance the activation of nuclear factor of activated T cells.

Authors:  Wei Ding; Björn Albrecht; Robert E Kelley; Natarajan Muthusamy; Seung-Jae Kim; Ruth A Altschuld; Michael D Lairmore
Journal:  J Virol       Date:  2002-10       Impact factor: 5.103

Review 6.  Leukemogenesis of adult T-cell leukemia.

Authors:  Jun-ichirou Yasunaga; Masao Matsuoka
Journal:  Int J Hematol       Date:  2003-11       Impact factor: 2.490

Review 7.  T-cell control by human T-cell leukemia/lymphoma virus type 1.

Authors:  Genoveffa Franchini; Risaku Fukumoto; Jake R Fullen
Journal:  Int J Hematol       Date:  2003-11       Impact factor: 2.490

8.  Human T-cell lymphotropic virus type 1 p12I enhances interleukin-2 production during T-cell activation.

Authors:  Wei Ding; Seung-Jae Kim; Amrithraj M Nair; Bindhu Michael; Kathleen Boris-Lawrie; Adam Tripp; Gerold Feuer; Michael D Lairmore
Journal:  J Virol       Date:  2003-10       Impact factor: 5.103

Review 9.  Pathogenesis and treatment of human T-cell leukemia virus infection.

Authors:  Lee Ratner
Journal:  Immunol Res       Date:  2005       Impact factor: 2.829

Review 10.  Critical role of human T-lymphotropic virus type 1 accessory proteins in viral replication and pathogenesis.

Authors:  Björn Albrecht; Michael D Lairmore
Journal:  Microbiol Mol Biol Rev       Date:  2002-09       Impact factor: 11.056

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.